Searched for
CNS AGENT
Suven Life gets product patents from Brazil, EurasiaThe granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurode...- Suven Life gets product patents from Australia, Hong KongThese patents are valid till 2036 and 2033 respectively, the company said in a BSE filing.
- Suven Life gets product patents from India, S. Korea and SingaporeSuven Life Science said it has been granted a product patent by India, Singapore, South Korea and Israel each for a new chemical entity (NC...
- Suven Life gets product patents from New Zealand, NorwayThese patents are valid till 2034 and 2027, respectively, the company said in a BSE filing.
- Suven Life gets patents from Norway, South Korea, SingaporeThe granted claims pertain to new chemical entities (NCEs) developed by the firm to treat disorders associated with neurodegenerative disea...
- Suven gets product patents in China, Sri LankaThe two patents are valid through 2033 and 2032, respectively, the company said in a BSE filing.
- Suven gets product patents from India, USSuven Life said the granted claims of the patents are being developed as therapeutic agents and useful in treatment of cognitive impairment...
- Suven gets patent from Singapore for neurological moleculeSuven Life Sciences shares were trading 0.70 per cent up at Rs 223 on BSE.
- Suven Life secures product patent in JapanSuven Life said it has been granted "one process patent from Japan corresponding to the NCEs which are for the treatment of disorders assoc...
- Suven gets patent for CNS molecules from Canada, Hong KongThe new chemical entities (NCEs) are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders.
- Suven Life gets patents for neuro-degenerative drugWith these new patents, Suven has a total of 24 granted patents from Australia, 17 from Eurasia and 9 from Israel and 24 from the US.
- Suven Life gets patent for chemical molecules to be used in neuro-degenerative drugsIn a BSE filing, the company said that it 'secured patents from China and South Africa to the new chemical entities (NCE) for central nervo...
- Suven Life Sciences shares up over 4 per cent after new patentsShares of Suven Life Sciences rose by 4% after receiving patent from US & S Korea for CNS molecule, used for treating central nervous syste...
- Suven Life Sciences gets 3 patents in Canada, China, IndiaSuven Life has received three product patents in Canada, China and India for its new chemical entities for treatment of neurodegenerative d...
- FDA cracks down on wholesalers for illegal diversion of ‘Codeine’The seizure affects only the syrup that contains codeine phosphate, a narcotic substance commonly used in preparation of cough syrup.
- Suven Life gets three patent approvals for CNS moleculesDrug firm Suven Life Sciences today said it has received three product patents for CNS molecules, two from Eurasia and one from Canada.
- Suven receives two product patents associated with NeurodegenerativeSuven Life Sciences has received two product patents in Eurasia for two new chemical entities for the treatment of disorders associated wit...
- Suven Life Sciences receives first US product patentSuven Life Sciences has received its first product patent from the US Patent Office.
- Suven gets European Patent nod for two therapeutic agentsSuven Life Sciences on Tuesday said the European Patent Office (EPO) has granted patents to two of its therapeutic agents which are used in...
- Suven Life gets patents for 2 neurodegenerative NCEsSuven Life Sciences' two chemical entities for treatment of disorders associated with neurodegenerative diseases have received patents from...
Load More
